Exosome Therapy for the Treatment of Encephalitis and Autistic Spectrum Disorders - Single Course

Exosome Therapy for the Treatment of Encephalitis and Autistic Spectrum Disorders - Single Course is organized by Age Management Medicine Group (AMMG).

Credits: 1.0 CME

Description:
This presentation will include sequential PET brain imaging on a 22-year-old male who lost his ability to speak at age two following a vaccination. He was diagnosed with Autism. He had not been able to speak for 20 years when I began treating him; he is now able to speak somewhat and is starting speech therapy. The sequential PET scans will demonstrate a great visual of the reduction of brain infection. The PET gives a computerized calculation via numerical values that validate the increased brain activity in specific brain regions. Most of the time, the same multiple factors are the causation of both premature dementia and Autistic Spectrum disorders.

Course Objectives:
• Explain the evidence-based science behind the use of Exosomes as an adjunct to an Age Management Medicine practice in the areas of biomarkers, ways of treating disease and use of targeted delivery vehicles for therapeutic molecules.
• Learn essential scientific information for the use of Exosomes in Age Management Medicine and how to clinically apply this knowledge to individualized treatment plans to improve outcomes.
• Understand how Exosomes can be applied clinically to various areas such as cardiac health, cancer, retinal and optic nerve conditions and gastrointestinal diseases.

Additional details will be posted as soon as information is available.